Replies to post #166884 on Biotech Values

[BTH]

Why do you say CDX-1127 is a "dud?" Do you have supporting evidence?

The CDX-1127 trial is a fairly large trial. There is zero chatter from the science, academic, KOL, and patient communities re: CD27 or, better yet, CDX-1127 itself.

If this was something special, people would be chattering about it. I can't find a single KOL, or doctor interview, or testimonial regarding CD27 or CDX-1127, and this trial has been going on for some time now, and its not a small trial by any means.

IMO, stable disease is probably what will be the outcome here....but that wont stop the bankers from saying PD1 needs CDX-1127.